Effect of 1-β-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-jun dominant-negative mutant protein (TAM67)

Cell Growth and Differentiation

Volumn 7, Issue 5, 1996, Pages 603-613

  Grant, Steven ^a   Freemerman, Alex J ^a   Birrer, Michael J ^b   Martin, Heather A ^a   Turner, Amy J ^a   Szabo, Eva ^b   Chelliah, Jayamanthan ^a   David Jarvis, W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; CYTARABINE TRIPHOSPHATE; DNA FRAGMENT; MUTANT PROTEIN; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELETION MUTANT; HUMAN; HUMAN CELL; LEUKEMIA CELL; ONCOGENE C JUN; PRIORITY JOURNAL; PROTO ONCOGENE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CYTARABINE; CYTOTOXINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MUTATION; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TUMOR CELLS, CULTURED;

ARA;

EID: 0029802369     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Keating, M. J., McCredie, K. B., Bodey, G. P., Smith, T. L., Gehan, E., and Freireich, E. J. Improved prospects for long-term survival in adults with acute myelogenous leukemia. J. Am. Med, Assoc., 248: 2481-2486, 1982.
2. Mikita, T., and Beardsley, G. P. Functional consequences of the ar- abinofuranosylcytosine structural lesion in DNA. Biochemistry, 27: 4698-4705, 1988.
3. Kufe, D., Beardsley, G. P., Major, P. P., and Egan, E. M. Correlation of cytotoxicity with incorporation of ara-C into DNA. J. Biol. Chem., 255: 8997-9000, 1980.
4. Kaufmann, S. H. Induction of internucleolytic DMA cleavage in human acute myeloid leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870-5878, 1989.
5. Wyllie, A. H., Kerr, J. F., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
6. Kouzarides, T., and Ziff, E. The role of the leucine zipper in the fos-jun interaction. Nature (Lond.), 336: 646-651, 1988.
7. Lee, W., Mitchell, P., and Tijan, R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell, 49: 741-752, 1987.
8. Vogt, P. K., and Vos, T. J. Jun: oncogene and transcription factor. Adv. Cancer Res., 55: 1-55, 1990.
9. Gunji, H., Kharbanda, S., and Kufe, D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabino-furanosylcytosine. Cancer Res., 51: 6636-6642, 1991.
10. Rubin, E., Kharbanda, S., Gunji, H., Weichselbaum, R., and Kufe, D. cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway. Cancer Res., 52: 878-882, 1992.
11. Rubin, E., Kharbanda, S., Gunji, H., and Kufe, D. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide. Mol. Pharmacol., 39: 697-701, 1991.
12. Kharbanda, S., Datta, R., and Kufe, D. Regulation of c-jun expression in HL-60 leukemia cells by 1 -β-D-arabinofuranosylcytosine: potential involvement of a protein kinase C dependent mechanism. Biochemistry, 30: 7947-7952, 1991.
13. Brach, M. A., Herrmann, F., and Kufe, D. W. Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells. Blood, 79: 728-734, 1992.
14. Collate, F., Polentarutti, N., Sironi, M., and Mantovani, A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem., 267: 18278-18283, 1992.
15. Grant, S., Turner, A. J., Bartimole, T. M., Nelms, P. A., Joe, V. C., and Jarvis, W. D. Modulation of 1 -[β-D-Arabinofuranosyl]cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacologic inhibitors of protein kinase C. Oncol. Res., 6: 87-99, 1994.
16. Brown, P. H., Alani, R., Preis, L. H., Szabo, E., and Birrer, M. J. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene, 8: 877-886, 1993.
17. Brown, P. H., Chen, T. K., and Birrer, M. J. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene, 9: 791-799, 1993.
18. Young, R. S. K., and Fischer, G. A. The action of arabinofuranosylcytosine on synchronously growing populations of mammalian cells. Biochem. Biophys. Res. Commun., 32: 23-31, 1968.
19. Griffin, J., Munroe, D., Major, P., Kufe, D. Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis. Exp. Hematol., 10: 774-781, 1982.
20. Baker, S. J., Pawlita, M., Leutz, A., and Hoelzer, D. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells. Leukemia (Baltimore), 8: 1309-1317, 1994.
21. Gomez-Casares, M. T., Delgado, M. D., Lerga, A., Crespo, P., Quincoces, A. F., Richard, C., and Leon, J. Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells. Leukemia (Baltimore), 7: 1824-1833, 1993.
22. Sherman, M. L., Stone, R. M., Datta, R., Bernstein, S. H., and Kufe, D. W. Transcriptional and posttranscriptional regulation of c-jun expression during induction of monocytic differentiation. J. Biol. Chem., 265: 3320-3323, 1990.
23. Kharbanda, S., Rubin, E., Gunji, H., Hinz, H., Giovanella, B., Pantazis, P., and Kufe, D. Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells. Cancer Res., 51: 6636-6642, 1991.
24. Kolla, S. S., and Studzinski, G. P. Constitutive DNA binding of the low mobility forms of the AP-1 and SP-1 transcription factors in HL-60 cells resistant to 1 -β-D-arabinofuranosylcytosine. Cancer Res., 54: 1418 -1421, 1994.
25. Ritke, M. K., Bergoltz, V. V., Allan, W. P., and Yalowich, J. C. Increased c-jun/AP-1 levels in etoposide-resistant human leukemia K562 cells. Biochem. Pharm., 48: 525-533, 1994.
26. Goldstone, S. D., and Lavin, M. F. Prolonged expression of c-jun and associated activity of the transcription factor AP-1, during apoptosis in a human leukemic cell line. Oncogene, 9: 2305-2311, 1994.
27. Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R., and Johnson, E. M. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol., 127: 1717-1728, 1994.
28. Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M., and Rubin, L. L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron, 14: 927-939, 1995.
29. Domann, F. E., Levy, J. P., Birrer, M. J., and Bowden, G. T. Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor promotion in nude mice. Cell Growth & Differ., 5: 9-16, 1994.
30. Petrak, D., Memon, S. A., Birrer, M. J., Ashwell, J. D., and Zacharchuk, C. M. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J. Immunol., 153: 2046-2051, 1994.
31. Jarvis, W. D., Turner, A. J., Povirk, L. F., Traylor, R. S., and Grant, S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human myeloid leukemia cells by pharmacologic inhibitors of protein kinase C. Cancer Res., 54: 1707-1714, 1994.
32. Gorczyca, W., Gong, J., Ardelt, B., Traganos, F., and Darzynkiewicz, Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res., 53: 3186-3192, 1993.
33. Bertrand, R., Solary, F., O'Connor, P., Kohn, K. W., and Pommier, Y. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res., 277: 314-321, 1994.
34. Bullock, G., Ray, S., Reed, J., Miyashite, T., Ibrado, A. M., Huang, Y., and Bhalla, K. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Clin. Cancer Res., 1: 559-564, 1995.
35. Leuthy, J. D., and Holbrook, N. J. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res., 52: 5-10, 1992.
36. Hallahan, D. E., Sukhatme, V. P., Sherman, M. L., Virudachalam, S., Kufe, D., and Weichselbaum, R. R. Protein kinase C mediates X-ray inducibility of nuclear signal transducers egr-1 and c-jun. Proc. Natl. Acad. Sci. USA.
37. Leuthy, J. D., and Holbrook, N. J. The pathway regulating gadd153 induction in response to DNA damage is independent of protein kinase C and tyrosine kinases. Cancer Res., 54 (Suppl.): 1902s-1906s, 1994.
38. Bhalla, K., Nayak, R., and Grant, S. Isolation and characterization of a deoxycytidine-deficient human myeloid leukemia cell line highly resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res., 44: 5029-5037, 1984.
39. Gaynor, R., Simon, K., and Koeffler, P. Expression of c-jun during macrophage differentiation of HL-60 cells. Blood, 77: 2618-2623, 1991.
40. Kharbanda, S., Datta, R., Rubin, E., Nakamura, T., Hass, R., and Kufe, D. Regulation of c-jun expression during monocytic differentiation by okadaic acid. Cell Growth & Differ., 3: 391-399, 1992.
41. William, W., Wagner, F., Karin, M., and Kraft, A. S. Multiple doses of diacylglycerol and calcium ionophore are necessary to activate AP-1 enhancer activity and induce markers of macrophage differentiation. J. Biol. Chem., 265: 18166-18171, 1990.
42. Hass, R., Pfannkuche, H-J., Kharbanda, S., Gunji, H., Meyer, G., Hartmann, A., Hidaka, H., Resch, K., Kufe, D., and Goppelt-Strube, M. Protein kinase C activation and protoonoogene expression in differentiation/retrodifferentiation of human U-937 leukemia cells. Cell Growth & Differ., 2: 541-548, 1991.
43. Barendsen, N., Mueller, M., and Chen, B. Inhibition of TPA-induced monocytic differentiation in THP-1 human monocytic leukemia cells by staurosporine, a potent protein kinase C inhibitor. Leuk. Res., 14: 467-474, 1990.
44. Szabo, E., Preis, L. H., and Birrer, M. J. Constitutive cJun expression induces partial macrophage differentiation in U-937 cells. Cell Growth & Differ., 5: 439-446, 1994.
45. Kharbanda, S. M., Sherman, M. L., and Kufe, D. W. Transcriptional regulation of c-jun expression by arabinofuranosylcytosine in human myeloid leukemia cells. J. Clin. Invest., 86: 1517-1523, 1990.
46. Angel, P., Hattori, K., Smeal, T., and Karin, M. The jun proto-oncogene is positively regulated by its product. JUN/AP-1. Cell, 55: 875-885, 1988.
47. Filmus, J., and Buick, R. N. Relationship of c-myc expression to differentiation and proliferation in HL-60 cells. Cancer Res., 45: 822-825, 1985.
48. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Litttewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
49. Beere, H. M., Hickman, J. A., Morimoto, R. I., Parmar, R., Newbould, R., and Waters, C. M. Changes in HSC70 and c-myc in HL-60 cells engaging differentiation or apoptosis. Mol. Cell Differ., 1: 323-343, 1993.
50. Takimoto, M. J., Quinn, J. P., Farina, A. R., Staudt, L. M., and Levens, D. fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. J. Biol. Chem., 264: 8992-8999, 1989.
51. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
52. Freemerman, A. J., Turner, A. J., Birrer, M. J., Szabo, E., Valerie, K., and Grant, S. Role of the proto-oncogene c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. Mol. Pharmacol., in press, 1996.
53. Martin, S. J., Bradley, J. G., and Cotter, T. G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol., 79: 448-453, 1990.
54. Del Bino, G., Li, X., Traganos, F., and Darzynkiewicz, Z. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. Leukemia (Baltimore), 8: 281-288, 1993.
55. Solary, E., Bertrand, R., Kohn, K. W., and Pommier, Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood, 81: 1359-1368, 1993.
56. Sundstrom, C., and Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer, 17: 565-577, 1976.
57. Szabo, E., Preis, L. H., and Birrer, M. J. Constitutive c-Jun expression induces partial macrophage differentiation in U937 cells. Cell Growth & Differ., 5: 439-446, 1994.
58. Jarvis, D. W., Gewirtz, D., Povirk, L., Turner, A. J., Traylor, R., Pettit, G. R., and Grant, S. Effect of bryostatin 1 and other activators of protein kinase C on 1 -β-D-arabinofuranosylcytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochem. Pharmacol., 47: 839-852, 1994.
59. Jarvis, W. D., Fornari, F. A., Kolesnick, R. N., Browning, J. L., Gewirtz, D. A., and Grant, S. Attenuation of ceramide-induced apoptosis in human myeloid leukemia cells by diglyceride. J. Biol. Chem., 269: 31685-31692, 1994.
60. Jarvis, W. D., Turner, A. J., Povirk, L. F., Traylor, R. S., and Grant, S. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacologic inhibitors of protein kinase C. Cancer Res., 54: 1707-1714, 1994.
61. Grant, S., Jarvis, W. D., Swerdlow, P. S., Turner, A. J., Traylor, R. S., Wallace, H. J., Lin, P-S., Pettit, G. R., and Gewirtz, D. A. Potentiation of the activity of 1-β-D-arabinofuranosylcytosine by the macrocyclic lactone PKC activator bryostatin 1 is associated with enhanced fragmentation of mature DNA. Cancer Res., 52: 6270-6278, 1992.
62. Hass, R., Bartels, H., Topley, N., Hadam, M., Kohler, L., Goppelt-Strube, M., and Resch, K. TPA-induced differentiation and adhesion of U-937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface markers. Eur. J. Cell Biol., 48: 282-293, 1989.
63. Grant, S., Boise, L., Westin, E., Howe, C., Pettit, G. R., Turner, A., and McCrady, C. In vitro effect of bryostatin 1 on the metabolism and cytotoxicity of 1 -β-D-arabinofuranosylcytosine in human leukemia cells. Biochem Pharmacol., 42: 853-867, 1991.
64. Bhalla, K., MacLaughlin, W., Cole, J., Arlin, Z., Baker, M., Graham, G., and Grant, S. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity. Blood, 70: 568-571, 1987.
65. Khym, J. X. An analytical system for the rapid separation of tissue nucleotides at low pressure on conventional ion exchangers. Clin. Chem., 21: 1245-1252, 1975.
66. Chirgwin, J., Przybala, H., McDonald, R., and Rutter, W. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.